UK Research-grade Proteins Market Size & Outlook
UK research-grade proteins market, 2018-2030 (US$M)
Related Markets
UK research-grade proteins market highlights
- The UK research-grade proteins market generated a revenue of USD 46.6 million in 2023 and is expected to reach USD 141.9 million by 2030.
- The UK market is expected to grow at a CAGR of 17.2% from 2024 to 2030.
- In terms of segment, cytokines & growth factors was the largest revenue generating product in 2023.
- Cytokines & Growth Factors is the most lucrative product segment registering the fastest growth during the forecast period.
Research-grade proteins market data book summary
| Market revenue in 2023 | USD 46.6 million |
| Market revenue in 2030 | USD 141.9 million |
| Growth rate | 17.2% (CAGR from 2023 to 2030) |
| Largest segment | Cytokines & growth factors |
| Fastest growing segment | Cytokines & Growth Factors |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cytokines & Growth Factors, Antibodies, Immune checkpoint proteins, Virus Antigens, Enzymes, Recombinant Regulatory Protein, Hormones |
| Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Bio-Techne Corp, Sino Biological, Miltenyi Biotec, Proteintech Group, Prospec, New England Biolabs |
Other key industry trends
- In terms of revenue, UK accounted for 4.8% of the global research-grade proteins market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK research-grade proteins market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 141.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Research-grade Proteins Market Scope
Research-grade Proteins Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK research-grade proteins market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to research-grade proteins market will help companies and investors design strategic landscapes.
Cytokines & growth factors was the largest segment with a revenue share of 26.18% in 2023. Horizon Databook has segmented the UK research-grade proteins market based on cytokines & growth factors, antibodies, immune checkpoint proteins, virus antigens, enzymes, recombinant regulatory protein, hormones covering the revenue growth of each sub-segment from 2018 to 2030.
The UK-based biotech firms are outperforming their European counterparts in securing early-stage funding. Between 2018 and 2020, biotech start-ups in the country raised USD 3.6 billion, marking a 20% increase compared to the funds raised from 2015 to 2017.
Consequently, the country’s R&D services sector is poised for significant growth in the upcoming decade. Key industry players such as Fujifilm are making strategic investments in the UK to capitalize on the expanding biopharmaceutical domain.
For instance, in December 2021, the company announced a substantial investment of USD 532 million (£400 million) to expand its Contract Development and Manufacturing Organization (CDMO) facilities in Billingham, UK, including establishing a mammalian cell culture facility.
Reasons to subscribe to UK research-grade proteins market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK research-grade proteins market databook
-
Our clientele includes a mix of research-grade proteins market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK research-grade proteins market , including forecasts for subscribers. This country databook contains high-level insights into UK research-grade proteins market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK research-grade proteins market size, by product, 2018-2030 (US$M)
UK Research-grade Proteins Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
